XML 36 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activities

 

 

 

Options
Outstanding

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contract Terms
(in years)

 

 

Aggregate
Intrinsic
Values
(in thousands)

 

Balance as of December 31, 2020

 

 

435,342

 

 

$

0.52

 

 

 

9.19

 

 

$

415

 

Options granted

 

 

2,386,990

 

 

 

3.11

 

 

 

 

 

 

 

Options cancelled and forfeited

 

 

(25,551

)

 

 

1.86

 

 

 

 

 

 

 

Options exercised

 

 

(59,466

)

 

 

1.86

 

 

 

 

 

 

150

 

Balance as of September 30, 2021

 

 

2,737,315

 

 

$

2.74

 

 

 

9.33

 

 

$

41,727

 

Vested and expected to vest, September 30, 2021

 

 

2,737,315

 

 

$

2.74

 

 

 

9.33

 

 

$

41,727

 

Options exercisable as of September 30, 2021

 

 

206,339

 

 

$

0.31

 

 

 

8.39

 

 

$

3,646

 

Summary of Assumptions Used in Black-Scholes Model

The fair value of the Company’s stock option awards was estimated at the date of grant using a Black-Scholes option pricing model with the following assumptions for the nine months ended September 30, 2021:

 

Expected term (in years)

 

5.80 - 6.08

Expected volatility

 

78.25% - 79.57%

Risk-free interest rate

 

0.94% - 1.13%

Expected dividend yield

 

0.00%

Summary of Restricted Stock Awards

The activity for restricted stock awards is as follows:

 

 

 

Number of Shares

 

 

Weighted-Average
Grant Date Fair Value

 

Unvested at December 31, 2020

 

 

66,681

 

 

$

1.00

 

Granted

 

 

297,724

 

 

 

8.55

 

Vested

 

 

(15,766

)

 

 

1.42

 

Unvested at September 30, 2021(1)

 

 

348,639

 

 

 

7.03

 

 

(1) Includes 21,750 restricted stock awards granted in 2018 and still outstanding for the period ended September 30, 2021, subject to only performance conditions.

Summary of Share-based Compensation Expense

The following table sets forth stock-based compensation for stock options, restricted stock awards, and performance awards included in the Company’s consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development expense

 

$

297

 

 

$

45

 

 

$

626

 

 

$

220

 

General and administrative expense

 

 

939

 

 

 

4

 

 

 

1,957

 

 

 

14

 

Total stock-based compensation expense

 

$

1,236

 

 

$

49

 

 

$

2,583

 

 

$

234